Impax To Settle Investors' Quality-Control Suit For $8M
Impax Laboratories Inc. has reached an $8 million settlement with a class of shareholders who allege that the company downplayed U.S. Food and Drug Administration concerns over quality control at a...To view the full article, register now.
Already a subscriber? Click here to view full article